SAVED Score Can Predict Risk for VTE in Multiple Myeloma

FRIDAY, Aug. 16, 2019 -- For patients with multiple myeloma (MM) receiving immunomodulatory drugs (IMiDs), a risk assessment model, SAVED, can predict the risk for venous thromboembolism (VTE), according to a study published in the July issue of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news